These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 38505606)

  • 1. H-ferritin-nanocaged gadolinium nanoparticles for ultra-sensitive MR molecular imaging.
    Zhang J; Yuan C; Kong L; Zhu F; Yuan W; Zhang J; Hong J; Deng F; Chen Q; Chen C; Wang T; Zuo Z; Liang M
    Theranostics; 2024; 14(5):1956-1965. PubMed ID: 38505606
    [No Abstract]   [Full Text] [Related]  

  • 2. Target-switchable Gd(III)-DOTA/protein cage nanoparticle conjugates with multiple targeting affibody molecules as target selective T
    Kim H; Jin S; Choi H; Kang M; Park SG; Jun H; Cho H; Kang S
    J Control Release; 2021 Jul; 335():269-280. PubMed ID: 34044091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Stable Chelate-free Gadolinium Loaded Titanium Dioxide Nanoparticles for MRI-Guided Radionuclide Stimulated Cancer Treatment.
    Fang L; Huang H; Quirk JD; Zheng J; Shen D; Manion B; Mixdorf M; Karmakar P; Sudlow GP; Tang R; Achilefu S
    Curr Anal Chem; 2022 Aug; 18(7):826-835. PubMed ID: 36561765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual T
    Xu L; Hong SH; Sun Y; Sun Z; Shou K; Cheng K; Chen H; Huang D; Xu H; Cheng Z
    Nanomedicine; 2018 Aug; 14(6):1743-1752. PubMed ID: 29679743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A small MRI contrast agent library of gadolinium(III)-encapsulated supramolecular nanoparticles for improved relaxivity and sensitivity.
    Chen KJ; Wolahan SM; Wang H; Hsu CH; Chang HW; Durazo A; Hwang LP; Garcia MA; Jiang ZK; Wu L; Lin YY; Tseng HR
    Biomaterials; 2011 Mar; 32(8):2160-5. PubMed ID: 21167594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New dual mode gadolinium nanoparticle contrast agent for magnetic resonance imaging.
    Ghaghada KB; Ravoori M; Sabapathy D; Bankson J; Kundra V; Annapragada A
    PLoS One; 2009 Oct; 4(10):e7628. PubMed ID: 19893616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving the MR Imaging Sensitivity of Upconversion Nanoparticles by an Internal and External Incorporation of the Gd(3+) Strategy for in Vivo Tumor-Targeted Imaging.
    Du H; Yu J; Guo D; Yang W; Wang J; Zhang B
    Langmuir; 2016 Feb; 32(4):1155-65. PubMed ID: 26740341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineered magnetic hybrid nanoparticles with enhanced relaxivity for tumor imaging.
    Aryal S; Key J; Stigliano C; Ananta JS; Zhong M; Decuzzi P
    Biomaterials; 2013 Oct; 34(31):7725-32. PubMed ID: 23871540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving Longitudinal Transversal Relaxation Of Gadolinium Chelate Using Silica Coating Magnetite Nanoparticles.
    Xu K; Liu H; Zhang J; Tong H; Zhao Z; Zhang W
    Int J Nanomedicine; 2019; 14():7879-7889. PubMed ID: 31576129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-Microenvironment Relaxivity-Changeable Gd-Loaded Poly(L-lysine)/Carboxymethyl Chitosan Nanoparticles as Cancer-Recognizable Magnetic Resonance Imaging Contrast Agents.
    Jiang D; Zhang X; Yu D; Xiao Y; Wang T; Su Z; Liu Y; Zhang N
    J Biomed Nanotechnol; 2017 Mar; 13(3):243-54. PubMed ID: 29381026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. γ-Glutamyltranspeptidase-Triggered Intracellular Gadolinium Nanoparticle Formation Enhances the T
    Hai Z; Ni Y; Saimi D; Yang H; Tong H; Zhong K; Liang G
    Nano Lett; 2019 Apr; 19(4):2428-2433. PubMed ID: 30856326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanotemplate-engineered nanoparticles containing gadolinium for magnetic resonance imaging of tumors.
    Zhu D; Lu X; Hardy PA; Leggas M; Jay M
    Invest Radiol; 2008 Feb; 43(2):129-40. PubMed ID: 18197065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted Molecular Iron Oxide Contrast Agents for Imaging Atherosclerotic Plaque.
    Evans RJ; Lavin B; Phinikaridou A; Chooi KY; Mohri Z; Wong E; Boyle JJ; Krams R; Botnar R; Long NJ
    Nanotheranostics; 2020; 4(4):184-194. PubMed ID: 32637296
    [No Abstract]   [Full Text] [Related]  

  • 14. Enhancing T
    Marangoni VS; Neumann O; Henderson L; Kaffes CC; Zhang H; Zhang R; Bishnoi S; Ayala-Orozco C; Zucolotto V; Bankson JA; Nordlander P; Halas NJ
    Proc Natl Acad Sci U S A; 2017 Jul; 114(27):6960-6965. PubMed ID: 28630340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an Effective Tumor-Targeted Contrast Agent for Magnetic Resonance Imaging Based on Mn/H-Ferritin Nanocomplexes.
    Tullio C; Salvioni L; Bellini M; Degrassi A; Fiandra L; D'Arienzo M; Garbujo S; Rotem R; Testa F; Prosperi D; Colombo M
    ACS Appl Bio Mater; 2021 Nov; 4(11):7800-7810. PubMed ID: 34805780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide targeted tripod macrocyclic Gd(III) chelates for cancer molecular MRI.
    Zhou Z; Wu X; Kresak A; Griswold M; Lu ZR
    Biomaterials; 2013 Oct; 34(31):7683-93. PubMed ID: 23863450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lumazine Synthase Protein Nanoparticle-Gd(III)-DOTA Conjugate as a T1 contrast agent for high-field MRI.
    Song Y; Kang YJ; Jung H; Kim H; Kang S; Cho H
    Sci Rep; 2015 Oct; 5():15656. PubMed ID: 26493381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human aortic endothelial cell labeling with positive contrast gadolinium oxide nanoparticles for cellular magnetic resonance imaging at 7 Tesla.
    Loai Y; Sakib N; Janik R; Foltz WD; Cheng HL
    Mol Imaging; 2012 Apr; 11(2):166-75. PubMed ID: 22469244
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.